Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
European Review for Medical and Pharmacological Sciences|September 11, 2012
Anti-inflammatory effects of Hylomecon hylomeconoides in RAW 264.7 cellsH S Chae, O H Kang, J H Keum, et al.
Bone Marrow Transplantation|July 20, 2007
New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2Y S Chae, S K Sohn, J G Kim, et al.
The Korean Journal of Internal Medicine|August 26, 1999
Transesophageal echocardiographic detection of thoracic aortic plaque could noninvasively predict significant obstructive coronary artery diseaseH Y Kim, C J Kim, T H Rho, et al.
Physical Review Letters|February 4, 2014
Experimental demonstration of energy-chirp control in relativistic electron bunches using a corrugated pipeP Emma, M Venturini, K L F Bane, et al.
British Journal of Cancer|April 28, 2006
Phase II study of capecitabine and irinotecan combination chemotherapy in patients with advanced gastric cancerJ H Baek, J G Kim, S B Jeon, et al.
Journal of Neuroscience Research|September 6, 2001
Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursor protein in PC12 through a receptor-dependent pathwayH S Chae, J H Bach, M W Lee, et al.
Oncogene|August 16, 2006
Promoter CpG hypermethylation and downregulation of XAF1 expression in human urogenital malignancies: implication for attenuated p53 response to apoptotic stressesM-G Lee, J-S Huh, S-K Chung, et al.
European Review for Medical and Pharmacological Sciences|September 8, 2012
Antibacterial activity of bark of Alnus pendula against methicillin-resistant Staphylococcus aureusJ G Choi, M W Lee, S E Choi, et al.
Journal of Neurochemistry|July 4, 2001
C-terminal fragment of amyloid precursor protein induces astrocytosisJ H Bach, H S Chae, J C Rah, et al.
ESMO Open|August 26, 2021
Potential role of CMPK1, SLC29A1, and TLE4 polymorphisms in gemcitabine-based chemotherapy in HER2-negative metastatic breast cancer patients: pharmacogenetic study results from the prospective randomized phase II study of eribulin plus gemcitabine versus paclitaxel plus gemcitabine (KCSG-BR-13-11)E H Cho, J-Y Kim, S-A Im, et al.
Pageof 20